What does CHARM mean?
CHARM means Candesartan in Heart Failure assessment of Mortality and Morbidity
This acronym/slang usually belongs to Medical & Science category.
What is the abbreviation for Candesartan in Heart Failure assessment of Mortality and Morbidity?
Candesartan in Heart Failure assessment of Mortality and Morbidity can be abbreviated as CHARM
|
|
Most popular questions people look for before coming to this page
| Q: A: |
What does CHARM stand for? CHARM stands for "Candesartan in Heart Failure assessment of Mortality and Morbidity". |
| Q: A: |
How to abbreviate "Candesartan in Heart Failure assessment of Mortality and Morbidity"? "Candesartan in Heart Failure assessment of Mortality and Morbidity" can be abbreviated as CHARM. |
| Q: A: |
What is the meaning of CHARM abbreviation? The meaning of CHARM abbreviation is "Candesartan in Heart Failure assessment of Mortality and Morbidity". |
| Q: A: |
What is CHARM abbreviation? One of the definitions of CHARM is "Candesartan in Heart Failure assessment of Mortality and Morbidity". |
| Q: A: |
What does CHARM mean? CHARM as abbreviation means "Candesartan in Heart Failure assessment of Mortality and Morbidity". |
| Q: A: |
What is shorthand of Candesartan in Heart Failure assessment of Mortality and Morbidity? The most common shorthand of "Candesartan in Heart Failure assessment of Mortality and Morbidity" is CHARM. |
Abbreviations or Slang with similar meaning
- ACRE - Assessment of Catechesis and Religious Education
- AMPS - Assessment of Motor and Process Skills
- AVAL - Assessment of Vulnerability and Lethality
- HFSOA - Heart Failure Society of America
- HFSA - Heart Failure Society of America
- MMHD - Mortality and Morbidity in Hemodialysis
- MMIB - Mortality and Morbidity Investigation Bureau
- ABLE - ASSESSMENT OF BUS AND LORRY EMISSIONS BY DEVELOPINGAN OPTIMISED EUROPEAN METHODOLOGY AND COMPUTER MODEL
- CHARM - candesartan in heart failure assessment of reduction in mortality and morbidity
- HFSA - Heart Failure Society of American
- MMLC - Mortality and Morbidity Liaison Committee
- MMRW - Mortality and Morbidity Weekly
- ARDEP - Assessment of Research and Development in Eurocontrol Programmes
- CHARM - candesartan cilexitil in heart failure assessment of reduction mortality and morbidity
- hfsa - Heart Failure Society of America's
- M & Ms - mortality and morbidity conferences where medics discuss epidemics, mistakes and patient deaths
- SCD-HEFT - Sudden Cardiac Death In Heart Failure: Trial Of Prophylactic Amiodarone Vs Implantable Defibrillator Therapy
- CHARM - Candesartan In Heart Failure Assessment In Reduction Of Mortality
- MOCHA - Multicenter Oral Carvedilol In Heart Failure Assessment
- PHARM - Pharmacist In Heart Failure: Assessment, Recommendation And Monitoring